PAA 2.86% 18.0¢ pharmaust limited

Ann: Modification of Clinical Trial in Dogs, page-12

  1. 451 Posts.
    lightbulb Created with Sketch. 85
    This is a good result but I would not expect ANN on it in 7 days that is a little too optimistic. But at least we have the andwer that most suspected regarding the canine trials and that is that it is problematic to dose a canine over 28 days. Form my personal experience (and that does make it count for nothing) when our dog was diagnosed with Cancer she immediately went off eating anything and the advice we were given was to put her down immediatley top stop the suffering. So with that in mind while I have high hopes for the drug I always expected it to be very difficult to get a dosage strategy up and running with owners effectively would be difficult.

    I hope now with a shortage dosage cycle that wee can get to the end of the Phase 1 trial on canines with a result matching the humans that will be the positive. But I woul think announcements on results are in the months not days category.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.005(2.86%)
Mkt cap ! $87.51M
Open High Low Value Volume
17.5¢ 18.3¢ 17.5¢ $205.5K 1.150M

Buyers (Bids)

No. Vol. Price($)
2 55777 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 56756 2
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.